<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0864-2125</journal-id>
<journal-title><![CDATA[Revista Cubana de Medicina General Integral]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Med Gen Integr]]></abbrev-journal-title>
<issn>0864-2125</issn>
<publisher>
<publisher-name><![CDATA[ECIMED]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0864-21252002000300016</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Índice de materia]]></article-title>
</title-group>
<aff id="A">
<institution><![CDATA[,  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2002</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2002</year>
</pub-date>
<volume>18</volume>
<numero>3</numero>
<fpage>239</fpage>
<lpage>239</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0864-21252002000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0864-21252002000300016&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0864-21252002000300016&amp;lng=en&amp;nrm=iso"></self-uri></article-meta>
</front><body><![CDATA[  <h3>Resumed</h3> <h2> Índice de materia </h2> <table width="75%" border="1">   <tr>      <td>AGENTES ANTIINFLAMATORIOS NO ESTEROIDES,</td>     <td>1 </td>   </tr>   <tr>      <td>ANAMNESIS,</td>     <td>2 </td>   </tr>   <tr>      <td>CLARITROMICINA/uso terapéutico,</td>     <td>7 </td>   </tr>   <tr>      <td>COMBINACIÓN DE MEDICAMENTOS, </td>     <td>7 </td>   </tr>   <tr>      <td>DIRECTRICES PARA LA PLANIFICACIÓN EN SALUD,</td>     <td>10 </td>   </tr>   <tr>      <td>DISPEPSIA, </td>     <td>3,6</td>   </tr>   <tr>      <td>DISPEPSIA/etiología, </td>     <td>2 </td>   </tr>   <tr>      <td>EFECTOS DE DESASTRES EN LA SALUD,</td>     <td>1 </td>   </tr>   <tr>      <td>ENFERMEDADES GASTROINTESTINALES,</td>     <td>10 </td>   </tr>   <tr>      <td>ENSAYO CONTROLADO ALEATORIOS,</td>     <td>6 </td>   </tr>   <tr>      <td>ESTRÉS PSICOLÓGICO,</td>     <td>1,11 </td>   </tr>   <tr>      <td>ESTUDIOS EPIDEMIOLÓGICOS,</td>     <td>3,4</td>   </tr>   <tr>      <td>EXAMEN FÍSICO, </td>     <td>2 </td>   </tr>   <tr>      <td>GASTRITIS ATRÓFICA,</td>     <td>9 </td>   </tr>   <tr>      <td>HELICOBACTER PYLORI,</td>     <td>1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11</td>   </tr>   <tr>      <td>INTESTINOS/patología, </td>     <td>9 </td>   </tr>   <tr>      <td>METAANÁLISIS,</td>     <td>6 </td>   </tr>   <tr>      <td>METAPLASIA, </td>     <td>9 </td>   </tr>   <tr>      <td>PÓLIPOS,</td>     <td>8 </td>   </tr>   <tr>      <td>OMEPRAZOL,</td>     <td>5 </td>   </tr>   <tr>      <td>TÉCNICAS DE DIAGNÓSTICOS DEL SISTEMA DIGESTIVO/métodos</td>     <td>2, 10</td>   </tr>   <tr>      <td>TERAPIA COMBINADA, </td>     <td>6, 8, 9, 10 </td>   </tr>   <tr>      <td>ÚLCERA PÉPTICA, </td>     <td>11</td>   </tr>   <tr>      <td>ÚLCERA PÉPTICA/etiología,</td>     <td>1, 4</td>   </tr>   <tr>     <td height="22">ÚLCERA PÉPTICA/quimioterapia,</td>     <td height="22">5 </td>   </tr> </table>     <p>&nbsp;</p>      ]]></body>
</article>
